Addition of glycosylation to influenza a virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 2169-2177

  Job, Emma R ^a   Deng, Yi Mo ^b   Barfod, Kenneth K ^a   Tate, Michelle D ^a,e   Caldwell, Natalie ^b   Reddiex, Scott ^a,e   Maurer Stroh, Sebastian ^c,d   Brooks, Andrew G ^a   Reading, Patrick C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c BIOINFORMATICS INSTITUTE   (Singapore)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLECTIN; GLYCAN; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS RNA;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GENETIC ENGINEERING; IMMUNE EVASION; IN VIVO STUDY; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; MALE; MDCK CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; VIROGENESIS; VIRUS NEUTRALIZATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ASPARAGINE; COLLECTINS; DOGS; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; MICE; MUTATION; REVERSE GENETICS; SEASONS;

EID: 84874270957     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202433     Document Type: Article

References (71)

1. Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54: 631-664.
2. Zhang, M., B. Gaschen, W. Blay, B. Foley, N. Haigwood, C. Kuiken, and B. Korber. 2004. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14: 1229-1246.
3. Igarashi, M., K. Ito, H. Kida, and A. Takada. 2008. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 376: 323-329.
4. Sun, S., Q. Wang, F. Zhao, W. Chen, and Z. Li. 2011. Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS ONE 6: e22844.
5. Caton, A. J., G. G. Brownlee, J. W. Yewdell, and W. Gerhard. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427.
6. Schulze, I. T. 1997. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J. Infect. Dis. 176(Suppl 1): S24-S28.
7. Skehel, J. J., D. J. Stevens, R. S. Daniels, A. R. Douglas, M. Knossow, I. A. Wilson, and D. C. Wiley. 1984. A carbohydrate side chain of hemagglutinin of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 81: 1779-1783.
8. Abe, Y., E. Takashita, K. Sugawara, Y. Matsuzaki, Y. Muraki, and S. Hongo. 2004. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 78: 9605-9611.
9. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69: 531-569.
10. Seidel, W., F. Künkel, B. Geisler, W. Garten, B. Herrmann, L. Döhner, and H. D. Klenk. 1991. Intraepidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch. Virol. 120: 289-296.
11. Tsuchiya, E., K. Sugawara, S. Hongo, Y. Matsuzaki, Y. Muraki, Z. N. Li, and K. Nakamura. 2001. Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J. Gen. Virol. 82: 2475-2484.
12. Crouch, E., K. Hartshorn, and I. Ofek. 2000. Collectins and pulmonary innate immunity. Immunol. Rev. 173: 52-65.
13. Reading, P. C., M. D. Tate, D. L. Pickett, and A. G. Brooks. 2007. Glycosylation as a target for recognition of influenza viruses by the innate immune system. Adv. Exp. Med. Biol. 598: 279-292.
14. Hartshorn, K. L., M. R. White, V. Shepherd, K. Reid, J. C. Jensenius, and E. C. Crouch. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum protection. Am. J. Physiol. 273: L1156-L1166.
15. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectinmediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71: 8204-8212.
16. Hartshorn, K. L., K. Sastry, M. R. White, E. M. Anders, M. Super, R. A. Ezekowitz, and A. I. Tauber. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91: 1414-1420.
17. Fidler, K. J., T. N. Hilliard, A. Bush, M. Johnson, D. M. Geddes, M. W. Turner, E. W. Alton, N. J. Klein, and J. C. Davies. 2009. Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax 64: 150-155.
18. Hartshorn, K. L., M. R. White, D. R. Voelker, J. Coburn, K. Zaner, and E. C. Crouch. 2000. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem. J. 351: 449-458.
19. Eda, S., Y. Suzuki, T. Kawai, K. Ohtani, T. Kase, Y. Fujinaga, T. Sakamoto, T. Kurimura, and N. Wakamiya. 1997. Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus. Biochem. J. 323: 393-399.
20. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J. Immunol. 187: 1884-1894.
21. Vigerust, D. J., K. B. Ulett, K. L. Boyd, J. Madsen, S. Hawgood, and J. A. McCullers. 2007. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 81: 8593-8600.
22. Tate, M. D., E. R. Job, A. G. Brooks, and P. C. Reading. 2011. Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. Virology 413: 84-92.
23. World Health Organization. 2009. Director-General statement following the meeting of the Emergency Committee. Available at: http://www.who.int/csr/ disease/swineflu/4th-meeting-ihr/en/index.html. Accessed: January 1, 2013.
24. Palese, P., and T. T. Wang. 2011. Why do influenza virus subtypes die out? A hypothesis. MBio 2: e00150-11.
25. World Health Organization. 2012. Recommended composition of influenza virus vaccines for use in the 2012 southern hemisphere influenza season. Available at: http://www.who.int/influenza/vaccines/virus/recommendations/ 2012south/en/. Accessed January 1, 2013.
26. Anders, E. M., C. A. Hartley, P. C. Reading, and R. A. Ezekowitz. 1994. Complement-dependent neutralization of influenza virus by a serum mannosebinding lectin. J. Gen. Virol. 75: 615-622.
27. Anders, E. M., C. A. Hartley, and D. C. Jackson. 1990. Bovine and mouse serum b inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 87: 4485-4489.
28. Hartshorn, K., D. Chang, K. Rust, M. White, J. Heuser, and E. Crouch. 1996. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am. J. Physiol. 271: L753-L762.
29. Dean, M. M., S. Heatley, and R. M. Minchinton. 2006. Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function. Mol. Immunol. 43: 950-961.
30. Hoffmann, E., S. Krauss, D. Perez, R. Webby, and R. G. Webster. 2002. Eightplasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
31. Job, E. R., Y. M. Deng, M. D. Tate, B. Bottazzi, E. C. Crouch, M. M. Dean, A. Mantovani, A. G. Brooks, and P. C. Reading. 2010. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 185: 4284-4291.
32. Hensley, S. E., S. R. Das, A. L. Bailey, L. M. Schmidt, H. D. Hickman, A. Jayaraman, K. Viswanathan, R. Raman, R. Sasisekharan, J. R. Bennink, and J. W. Yewdell. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736.
33. Reading, P. C., D. L. Pickett, M. D. Tate, P. G. Whitney, E. R. Job, and A. G. Brooks. 2009. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 10: 117.
34. Brown, L. E., C. W. Ward, and D. C. Jackson. 1982. Antigenic determinants of influenza virus hemagglutinin - IX. The carbohydrate side chains from an Asian strain. Mol. Immunol. 19: 329-338.
35. Ward, C. W., and T. A. Dopheide. 1981. Amino acid sequence and oligosaccharide distribution of the haemagglutinin from an early Hong Kong influenza virus variant A/Aichi/2/68 (X-31). Biochem. J. 193: 953-962.
36. Bohne-Lang, A., and C. W. von der Lieth. 2005. GlyProt: in silico glycosylation of proteins. Nucleic Acids Res. 33(Web Server issue): W214-W219.
37. Xu, R., D. C. Ekiert, J. C. Krause, R. Hai, J. E. Crowe, Jr., and I. A. Wilson. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360.
38. Krieger, E., K. Joo, J. Lee, J. Lee, S. Raman, J. Thompson, M. Tyka, D. Baker, and K. Karplus. 2009. Improving physical realism, stereochemistry, and sidechain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins 77(Suppl 9): 114-122.
39. Konagurthu, A. S., J. C. Whisstock, P. J. Stuckey, and A. M. Lesk. 2006. MUSTANG: a multiple structural alignment algorithm. Proteins 64: 559-574.
40. Fleury, D., B. Barrère, T. Bizebard, R. S. Daniels, J. J. Skehel, and M. Knossow. 1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Biol. 6: 530-534.
41. Fleury, D., R. S. Daniels, J. J. Skehel, M. Knossow, and T. Bizebard. 2000. Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins 40: 572-578.
42. Igarashi, M., K. Ito, R. Yoshida, D. Tomabechi, H. Kida, and A. Takada. 2010. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5: e8553.
43. Vigerust, D. J., and V. L. Shepherd. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15: 211-218.
44. Hartshorn, K. L., R. Webby, M. R. White, T. Tecle, C. Pan, S. Boucher, R. J. Moreland, E. C. Crouch, and R. K. Scheule. 2008. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 9: 65.
45. Gerhard, W., J. Yewdell, M. E. Frankel, and R. Webster. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290: 713-717.
46. Reiss, C. S., and J. L. Schulman. 1980. Cellular immune responses of mice to influenza virus vaccines. J. Immunol. 125: 2182-2188.
47. McMichael, A. J., F. Gotch, P. Cullen, B. Askonas, and R. G. Webster. 1981. The human cytotoxic T cell response to influenza A vaccination. Clin. Exp. Immunol. 43: 276-284.
48. Centers for Disease Control and Prevention (CDC). 2011. Severe illness from 2009 pandemic influenza A (H1N1) - Utah, 2009-10 influenza season. MMWR Morb. Mortal. Wkly. Rep. 60: 1310-1314.
49. Wei, C. J., J. C. Boyington, K. Dai, K. V. Houser, M. B. Pearce, W. P. Kong, Z. Y. Yang, T. M. Tumpey, and G. J. Nabel. 2010. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2: 24ra21.
50. Sun, S., Q. Wang, F. Zhao, W. Chen, and Z. Li. 2012. Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses. PLoS ONE 7: e32119.
51. Jambo, K. C., N. French, E. Zijlstra, and S. B. Gordon. 2007. AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid. Respir. Res. 8: 42.
52. Sims, M. W., R. M. Tal-Singer, S. Kierstein, A. I. Musani, M. F. Beers, R. A. Panettieri, and A. Haczku. 2008. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir. Res. 9: 13.
53. Postle, A. D., A. Mander, K. B. Reid, J. Y. Wang, S. M. Wright, M. Moustaki, and J. O. Warner. 1999. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 20: 90-98.
54. Hansen, S., and U. Holmskov. 2002. Lung surfactant protein D (SP-D) and the molecular diverted descendants: conglutinin, CL-43 and CL-46. Immunobiology 205: 498-517.
55. Collins, J. K., and C. A. Knight. 1978. Purification of the influenza hemagglutinin glycoprotein and characterization of its carbohydrate components. J. Virol. 26: 457-467.
56. Schwarz, R. T., and H. D. Klenk. 1981. Carbohydrates of influenza virus. IV. Strain-dependent variations. Virology 113: 584-593.
57. Basak, S., D. G. Pritchard, A. S. Bhown, and R. W. Compans. 1981. Glycosylation sites of influenza viral glycoproteins: characterization of tryptic glycopeptides from the A/USSR(H1N1) hemagglutinin glycoprotein. J. Virol. 37: 549-558.
58. Hartley, C. A., D. C. Jackson, and E. M. Anders. 1992. Two distinct serum mannose-binding lectins function as b inhibitors of influenza virus: identification of bovine serum b inhibitor as conglutinin. J. Virol. 66: 4358-4363.
59. Das, S. R., S. E. Hensley, A. David, L. Schmidt, J. S. Gibbs, P. Puigbò, W. L. Ince, J. R. Bennink, and J. W. Yewdell. 2011. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc. Natl. Acad. Sci. USA 108: E1417-E1422.
60. Xu, L., L. Bao, Q. Lv, W. Deng, Y. Ma, F. Li, L. Zhan, H. Zhu, C. Ma, and C. Qin. 2010. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol. J. 7: 325.
61. Zheng, B., K. H. Chan, A. J. Zhang, J. Zhou, C. C. Chan, V. K. Poon, K. Zhang, V. H. Leung, D. Y. Jin, P. C. Woo, et al. 2010. D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice. Exp. Biol. Med. (Maywood) 235: 981-988.
62. Chan, K. H., A. J. Zhang, K. K. To, C. C. Chan, V. K. Poon, K. Guo, F. Ng, Q.W. Zhang, V. H. Leung, A. N. Cheung, et al. 2010. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS ONE 5: e13757.
63. Belser, J. A., A. Jayaraman, R. Raman, C. Pappas, H. Zeng, N. J. Cox, J. M. Katz, R. Sasisekharan, and T. M. Tumpey. 2011. Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS ONE 6: e25091.
64. Kilander, A., R. Rykkvin, S. G. Dudman, and O. Hungnes. 2010. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A (H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 15: 19498.
65. Chen, H., X. Wen, K. K. To, P. Wang, H. Tse, J. F. Chan, H. W. Tsoi, K. S. Fung, C. W. Tse, R. A. Lee, et al. 2010. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J. Infect. Dis. 201: 1517-1521.
66. Mak, G. C., C. K. Leung, K. C. Cheng, K. Y. Wong, and W. Lim. 2011. Evolution of the haemagglutinin gene of the influenza A(H1N1)2009 virus isolated in Hong Kong, 2009-2011. Euro Surveill. 16: 19807.
67. Kumlin, U., S. Olofsson, K. Dimock, and N. Arnberg. 2008. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir. Viruses 2: 147-154.
68. Barr, I. G., L. Cui, N. Komadina, R. T. Lee, R. T. Lin, Y. Deng, N. Caldwell, R. Shaw, and S. Maurer-Stroh. 2010. A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill. 15: 19692.
69. Maurer-Stroh, S., R. T. Lee, F. Eisenhaber, L. Cui, S. P. Phuah, and R. T. Lin. 2010. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr. 2: RRN1162.
70. Strengell, M., N. Ikonen, T. Ziegler, and I. Julkunen. 2011. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. PLoS ONE 6: e25848.
71. Ye, J., E. M. Sorrell, Y. Cai, H. Shao, K. Xu, L. Pena, D. Hickman, H. Song, M. Angel, R. A. Medina, et al. 2010. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog. 6: e1001145.